128 related articles for article (PubMed ID: 33161795)
1. Analysis of hospital incidence and direct medical costs of intrahepatic cholangiocarcinoma in Spain (2000-2018).
Darbà J; Marsà A
Expert Rev Pharmacoecon Outcomes Res; 2021 Jun; 21(3):425-431. PubMed ID: 33161795
[TBL] [Abstract][Full Text] [Related]
2. Hospital incidence, mortality and costs of Alzheimer's disease in Spain: a retrospective multicenter study.
Darbà J; Marsà A
Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):1101-1106. PubMed ID: 32928002
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological aspects of biliary tree tumors in a region of northern Italy: emerging trends and sex-based differences.
Floreani A; Lisiero M; Baldovin T; Baldo V
Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1347-51. PubMed ID: 24081106
[TBL] [Abstract][Full Text] [Related]
4. Atopic dermatitis in specialized centers in Spain: a retrospective analysis of incidence and costs (2000-2017).
Darbà J; Marsà A
Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):737-742. PubMed ID: 32940085
[TBL] [Abstract][Full Text] [Related]
5. Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical Trials.
Lamarca A; Ross P; Wasan HS; Hubner RA; McNamara MG; Lopes A; Manoharan P; Palmer D; Bridgewater J; Valle JW
J Natl Cancer Inst; 2020 Feb; 112(2):200-210. PubMed ID: 31077311
[TBL] [Abstract][Full Text] [Related]
6. Patient characteristics and hospitalisation costs of spinal muscular atrophy in Spain: a retrospective multicentre database analysis.
Darbà J; Marsà A
BMJ Open; 2019 Nov; 9(11):e031271. PubMed ID: 31753879
[TBL] [Abstract][Full Text] [Related]
7. Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017.
Javle M; Lee S; Azad NS; Borad MJ; Kate Kelley R; Sivaraman S; Teschemaker A; Chopra I; Janjan N; Parasuraman S; Bekaii-Saab TS
Oncologist; 2022 Oct; 27(10):874-883. PubMed ID: 35972334
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
[TBL] [Abstract][Full Text] [Related]
9. The reality of cholangiocarcinoma in India- real world data from a tertiary referral centre.
Patkar S; Gupta V; Khobragade K; Goel M
HPB (Oxford); 2022 Sep; 24(9):1511-1518. PubMed ID: 35379594
[TBL] [Abstract][Full Text] [Related]
10. A significant cancer burden and high mortality of intrahepatic cholangiocarcinoma in Thailand: a nationwide database study.
Treeprasertsuk S; Poovorawan K; Soonthornworasiri N; Chaiteerakij R; Thanapirom K; Mairiang P; Sawadpanich K; Sonsiri K; Mahachai V; Phaosawasdi K
BMC Gastroenterol; 2017 Jan; 17(1):3. PubMed ID: 28056836
[TBL] [Abstract][Full Text] [Related]
11. Incidence, mortality and medical costs of patients hospitalized with melanoma in Spain: a retrospective multicentre observational study.
Darbà J; Marsà A
Curr Med Res Opin; 2021 May; 37(5):795-800. PubMed ID: 33591848
[TBL] [Abstract][Full Text] [Related]
12. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States.
Welzel TM; McGlynn KA; Hsing AW; O'Brien TR; Pfeiffer RM
J Natl Cancer Inst; 2006 Jun; 98(12):873-5. PubMed ID: 16788161
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, Risk Factors, and Survival of Patients with Intrahepatic Cholangiocarcinoma.
Chinchilla-López P; Aguilar-Olivos NE; García-Gómez J; Hernández-Alejandro KK; Chablé-Montero F; Motola-Kuba D; Patel T; Méndez-Sánchez N
Ann Hepatol; 2017; 16(4):565-568. PubMed ID: 28611259
[TBL] [Abstract][Full Text] [Related]
14. Multimodality treatment of intrahepatic cholangiocarcinoma: A review.
Simo KA; Halpin LE; McBrier NM; Hessey JA; Baker E; Ross S; Swan RZ; Iannitti DA; Martinie JB
J Surg Oncol; 2016 Jan; 113(1):62-83. PubMed ID: 26797780
[TBL] [Abstract][Full Text] [Related]
15. Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002.
Jepsen P; Vilstrup H; Tarone RE; Friis S; Sørensen HT
J Natl Cancer Inst; 2007 Jun; 99(11):895-7. PubMed ID: 17551150
[TBL] [Abstract][Full Text] [Related]
16. Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014.
Antwi SO; Mousa OY; Patel T
Ann Hepatol; 2018 July - August ,; 17(4):604-614. PubMed ID: 29893702
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology, management and costs of sepsis in Spain (2008-2017): a retrospective multicentre study.
Darbà J; Marsà A
Curr Med Res Opin; 2020 Jul; 36(7):1089-1095. PubMed ID: 32329375
[No Abstract] [Full Text] [Related]
18. Epidemiology of intrahepatic, perihilar, and distal cholangiocarcinoma in the French population.
Al Mahjoub A; Bouvier V; Menahem B; Bazille C; Fohlen A; Alves A; Mulliri A; Launoy G; Lubrano J
Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):678-684. PubMed ID: 30633038
[TBL] [Abstract][Full Text] [Related]
19. Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise.
Saha SK; Zhu AX; Fuchs CS; Brooks GA
Oncologist; 2016 May; 21(5):594-9. PubMed ID: 27000463
[TBL] [Abstract][Full Text] [Related]
20. Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis.
Rozenbaum MH; Mangen MJ; Huijts SM; van der Werf TS; Postma MJ
Vaccine; 2015 Jun; 33(28):3193-9. PubMed ID: 25981488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
